The concept of cellular immunotherapy fluctuated and declined. Jimin Medical and Nanhua Biotech fell to a standstill, Tailin Biotech fell by more than 8%, and Nanjing Xinbai and Sihuan Biotech followed suit.
The concept of cellular immunotherapy fluctuated and declined. Jimin Medical and Nanhua Biotech fell to a standstill, Tailin Biotech fell by more than 8%, and Nanjing Xinbai and Sihuan Biotech followed suit.
Dragon Tiger List | Zhongtong Bus received 110 million yuan in capital, and many investors joined the list and built up electronics
The top three net purchases were Zhongtong Bus, Nanjing Xinbai, and Coney Electromechanical
Express News | Nanjing Xinbai: There have been no major adjustments or changes in production and operation
The A-share genetic testing concept soared again, and Kaineng Health 20CM rose or stopped
Gelonghui May 9 | Kaineng Health 20CM rose and stopped, Nanjing Xinbai and Zhongyuan Xiehe rose and stopped, and Guanhao Biotech rose more than 13%.
Is It Time To Consider Buying Nanjing Xinjiekou Department Store Co., Ltd. (SHSE:600682)?
Nanjing Xinjiekou Department Store Co., Ltd. (SHSE:600682), is not the largest company out there, but it saw a significant share price rise of 22% in the past couple of months on the SHSE. While
Express News | Nanjing Xinbai: The controlling shareholder and actual controller received the Securities Regulatory Commission's “Administrative Penalty and Market Ban Decision”
Is Nanjing Xinjiekou Department Store (SHSE:600682) Using Too Much Debt?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' When we thi
Express News | Liberal Arts Biotech: Net profit of 237 million yuan in 2023 fell 45.06% year on year
Some Investors May Be Worried About Nanjing Xinjiekou Department Store's (SHSE:600682) Returns On Capital
To find a multi-bagger stock, what are the underlying trends we should look for in a business? One common approach is to try and find a company with returns on capital employed (ROCE) that are increa
Is Now The Time To Look At Buying Nanjing Xinjiekou Department Store Co., Ltd. (SHSE:600682)?
Nanjing Xinjiekou Department Store Co., Ltd. (SHSE:600682), might not be a large cap stock, but it saw significant share price movement during recent months on the SHSE, rising to highs of CN¥8.2
Nanjing Xinbai (600682.SH): The company has no business related to robots or industrial mother machines
Gelonghui January 15 丨 Nanjing Xinbai (600682.SH) said on the investor interactive platform that the company has no business related to robots or industrial mother machines.
Nanjing Xinbai (600682.SH): The mechanical and electrical products exported by Nanjing Nanfang are mainly household hardware tools
Gelonghui, January 12丨Nanjing Xinbai (600682.SH) said on the investor interactive platform that the mechanical and electrical products exported by its subsidiary Nanjing Nanfang are mainly household hardware tools.
Nanjing Xinbai (600682.SH): No business dealings with HOF in the UK
Gelonghui, January 10 | Nanjing Xinbai (600682.SH) said on an interactive platform that on August 10, 2018, the UK HOF and related operating entities entered bankruptcy management and were taken over by the bankruptcy administrator. The company lost control of the above operating entities and was no longer included in the scope of the company's consolidated financial statements. The company has no business dealings with HOF in the UK.
Investors Three-year Losses Continue as Nanjing Xinjiekou Department Store (SHSE:600682) Dips a Further 6.0% This Week, Earnings Continue to Decline
For many investors, the main point of stock picking is to generate higher returns than the overall market. But if you try your hand at stock picking, your risk returning less than the market. Unfort
Yuan Yafei, the daughter of the “former richest man in Nanjing”, will become the vice president of Nanjing Xinbai, and the second generation of “post-95” enterprises will officially take the stage
① Yuan Qianhui, the daughter of Yuan Yafei, the “former richest man in Nanjing,” became the vice president of Nanjing Xinbai; ② Zhang Lei, another “post-80s” vice president nominated by Nanjing Xinbai this time, resigned as a director on the same day, or “made room” for Yuan Qianhui.
A-share innovative drug concept stocks bottomed out and rebounded, Nanjing Xinbai pulled up and stopped rising
Gelonghui December 7 | Shanghai Yizhong, Zhendong Pharmaceutical, Haichuang Pharmaceutical, and Zejing Pharmaceutical rose more than 5%. According to the news, Hong Kong stock innovative drug leader Pharmacoming Biotech recently announced that according to the repurchase authorization, the company was allowed to repurchase up to 425 million shares from the Hong Kong Stock Exchange, accounting for 10% of the total number of shares issued on the day of the Annual General Meeting of Shareholders.
Does Nanjing Xinjiekou Department Store (SHSE:600682) Have A Healthy Balance Sheet?
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility of prices, but whether you will suffer a permanent loss of capital.' So it seems
[BT Financial Report Instantaneous Analysis] Nanjing Xinbai's 2023 Third Quarterly Report Revealed: Diversified Layout Under Performance Pressure
Nanjing Xinbai (stock code: 600682) is a well-known department store retail enterprise in Jiangsu Province. Its business scope covers various fields such as department store retail business and property leasing. In addition to traditional retail business, Nanjing Xinbai actively lays out the health care industry. Through its subsidiaries Ankangtong and Jiangsu Hekang Pension Industry (Group) Co., Ltd., it provides a series of services including smart pension systems and pension call centers, and is committed to creating a one-stop pension solution. In terms of assets and liabilities, the total assets of Nanjing Xinbai increased from 25.215 billion yuan at the end of last year to 25.84 billion yuan at the end of this reporting period, an increase of 25.84 billion yuan
Nanjing Xinbai (600682) 2023 Third Quarter Report Review: Q3 Performance Is Under Pressure, Multiple Businesses Drive Growth
The operating income of 2023Q3 is -7.9%, net profit of the parent is -65.1%; the operating income of 2023Q1-Q3 is +2.0%, and the net profit of the mother is -35.2%. Modern Commerce: Commerce
[Instant Analysis of BT Financial Report] Nanjing Xinbai 2023 Interim Report: Net assets are growing steadily, balance ratio has declined, and performance is steady
Nanjing Xinbai (stock code: 600682) is a modern commercial company with department store retail as its main business. Its main business model is a joint venture model and a leasing model, and some stores use a small number of self-operated sales models. The company has many stores in Nanjing, Jiangsu, and Wuhu, Anhui, and provides property rental services. In addition, Nanjing Xinbai also has a major business in the field of health and old-age care, providing consumers with a variety of products and services. According to the Nanjing Xinbai 2023 Interim Report, total assets at the end of the period were 259 billion yuan, up from 252 billion yuan at the beginning of the period. This indicates that the company is in the first half of the year
No Data